Amikacin
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.
🧴 Clinical Application
Administered strictly by a qualified healthcare professional via intramuscular (IM) injection or slow intravenous (IV) infusion over 30 to 60 minutes. Not absorbable by the oral route. Dosage is calculated accurately based on ideal body weight and renal function.
⚠️ Side Effects
Common: Local injection pain, headache, mild nausea. Rare/Severe: Nephrotoxicity (elevation of serum creatinine, azotemia, acute tubular necrosis), ototoxicity (cochlear hearing loss and irreversible vestibular dysfunction), and neuromuscular blockade/respiratory paralysis.
🛡️ Safety Warnings
Black box warning: Nephrotoxicity and ototoxicity. Pre-existing renal impairment, dehydration, advanced age, and high trough levels heighten toxicity risk. Monitor serum creatinine, BUN, and audiometry. Avoid co-administration with other nephrotoxic/ototoxic drugs (loop diuretics, vancomycin, cisplatin, colistin).
Jan Aushadhi Products containing Amikacin
Found 3 generic formulation(s) containing this active ingredient.
Amikacin Injection 100 mg per 2 ml
Amikacin is a semisynthetic aminoglycoside bactericidal antibiotic derived from kanamycin. It irreversibly binds to the bacterial 30S ribosomal subunit, inducing misreading of mRNA genetic code and interfering with protein translation. Particularly effective against multidrug-resistant Gram-negative bacillary infections (Pseudomonas aeruginosa, Klebsiella, Enterobacter, Proteus, Serratia, and E. coli) and Mycobacterium tuberculosis in specialized second-line regimens.
Amikacin Injection 250 mg per 2 ml
Amikacin is a semisynthetic aminoglycoside bactericidal antibiotic derived from kanamycin. It irreversibly binds to the bacterial 30S ribosomal subunit, inducing misreading of mRNA genetic code and interfering with protein translation. Particularly effective against multidrug-resistant Gram-negative bacillary infections (Pseudomonas aeruginosa, Klebsiella, Enterobacter, Proteus, Serratia, and E. coli) and Mycobacterium tuberculosis in specialized second-line regimens.
Amikacin Injection 500 mg per 2 ml
Amikacin is a semisynthetic aminoglycoside bactericidal antibiotic derived from kanamycin. It irreversibly binds to the bacterial 30S ribosomal subunit, inducing misreading of mRNA genetic code and interfering with protein translation. Particularly effective against multidrug-resistant Gram-negative bacillary infections (Pseudomonas aeruginosa, Klebsiella, Enterobacter, Proteus, Serratia, and E. coli) and Mycobacterium tuberculosis in specialized second-line regimens.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Amikacin.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Amikacin Injection 100 mg per 2 ml | 2 ml Vial | ₹12.00 | AMIKAZIN | ₹10.80 | N/A |
| Amikacin Injection 250 mg per 2 ml | 2 ml Vial | ₹20.00 | MIKacin, Omnikacin, Macmika | ₹57.70 | 65% Save |
| Amikacin Injection 500 mg per 2 ml | 2 ml Vial | ₹27.19 | MIKACIN, AMICIP | ₹102.44 | 73% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Amikacin generics.